Twelve-Month Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Assessed Using an Empirically Pre-Defined Statistical Region-of-Interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's disease (AD) is characterized by specific and progressive reductions in fluorodeoxyglucose positron emission tomography (FDG PET) measurements of the cerebral metabolic rate for glucose (CMRgl), some of which may precede the onset of symptoms. In this report, we describe twelve-mont...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chen, Kewei, Langbaum, Jessica B.S., Fleisher, Adam S., Ayutyanont, Napatkamon, Reschke, Cole, Lee, Wendy, Liu, Xiaofen, Bandy, Dan, Alexander, Gene E., Thompson, Paul M., Foster, Norman L., Harvey, Danielle J., de Leon, Mony J., Koeppe, Robert A., Jagust, William J., Weiner, Michael W., Reiman, Eric M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856742/
https://ncbi.nlm.nih.gov/pubmed/20202480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2010.02.064
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg